Blog

Leading the Way in Effective Drug Development

National cancer institute N Fvd K Ihx Yl U unsplash e1590178113175
Mar 02, 2021

Tools for Improving Success in Oncology Trials

Approximately 17 million people globally are diagnosed with some form of cancer each year. Clinical studies seeking to develop new cancer therapies represent a large portion of all clinical research as sponsors and academics work to discover cures and methods for prolonging and improving the lives of patients. Unfortunately, oncology drugs suffer from a very low success rate in clinical trials – 3.4%.

Digital Tech
Feb 13, 2021

Why we made our digital biomarker code open source

There is little doubt regarding the usefulness and practicality of digital phenotyping to measure patient health and behavior. Traditional clinical scales––the current gold standards for primary endpoints––can be cumbersome and demanding.

National cancer institute L8t WZT4 Cc VQ unsplash e1590178142172
Feb 09, 2021

One or Two Weeks of Dosing Data is All You Need for an Optimized Patient Pool

Medication adherence can make or break a clinical trial. A lot of effort is spent by site teams engaging with patients to get them to take their medications regularly and correctly. This can be a real burden for sites, bogging them down and making everything go slower.

COVID 1
Jan 26, 2021

In Clinical Trials, Everything Starts with Dosing

Medication adherence, or whether patients take their medications reliably, is a fundamental indicator of patient engagement and a determining factor for whether or not a study will produce the necessary data to bring a new therapy to market.

Lei Guan
Jan 20, 2021

Looking Ahead: How Technology will Shape Clinical Research in 2021 and Beyond

Certainly, none of us will ever forget the year we just survived. 2020 brought challenges most of us never would have expected.

Ed Ikeblog
Jan 12, 2021

AI-Assisted, Decentralized Clinical Trials: Trial Sites Will Always be Crucial to Good Research

It may seem controversial for the CEO of a remote technology company in the clinical trials space to say that we can’t do what we do without clinical study sites. But I think it’s true.